john mcmurray

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Scotland

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Taylor G L; Murphy N F; Berry C; Christie J; Finlayson A; MacIntyre K; Morrison C; McMurray J
Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic.
Anavekar Nagesh S; Skali Hicham; Bourgoun Mikhail; Ghali Jalal K; Kober Lars; Maggioni Aldo P; McMurray John J V; Velazquez Eric; Califf Robert; Pfeffer Marc A; Solomon Scott D
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
McMurray John J V; Carson Peter E; Komajda Michel; McKelvie Robert; Zile Michael R; Ptaszynska Agata; Staiger Christoph; Donovan J Mark; Massie Barry M
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of john mcmurray (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Taylor G L; Murphy N F; Berry C; Christie J; Finlayson A; MacIntyre K; Morrison C; McMurray J
Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic.
Heart (British Cardiac Society) 2008;94(5):628-32.
2008: Anavekar Nagesh S; Skali Hicham; Bourgoun Mikhail; Ghali Jalal K; Kober Lars; Maggioni Aldo P; McMurray John J V; Velazquez Eric; Califf Robert; Pfeffer Marc A; Solomon Scott D
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
The American journal of cardiology 2008;101(5):607-12.
2008: McMurray John J V; Carson Peter E; Komajda Michel; McKelvie Robert; Zile Michael R; Ptaszynska Agata; Staiger Christoph; Donovan J Mark; Massie Barry M
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(2):149-56.
2008: Carrington Melinda; Murphy Niamh F; Strange Geoff; Peacock Andrew; McMurray John J V; Stewart Simon
Prognostic impact of pulmonary arterial hypertension: a population-based analysis.
International journal of cardiology 2008;124(2):183-7.
2008: Thomas Kevin L; Al-Khatib Sana M; Lokhnygina Yuliya; Solomon Scott D; Kober Lars; McMurray John J V; Califf Robert M; Velazquez Eric J
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
American heart journal 2008;155(1):87-93.
2008: Thune Jens J; Signorovitch James; Kober Lars; Velazquez Eric J; McMurray John J V; Califf Robert M; Maggioni Aldo P; Rouleau Jean L; Howlett Jonathan; Zelenkofske Steven; Pfeffer Marc A; Solomon Scott D
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Hypertension 2008;51(1):48-54.
2007: Myles Rachel C; Jackson Colette E; Tsorlalis Ioannis; Petrie Mark C; McMurray John J V; Cobbe Stuart M
Is microvolt T-wave alternans the answer to risk stratification in heart failure?
Circulation 2007;116(25):2984-91.
2007: Recio-Mayoral A; Kaski J-C; McMurray J J V; Horowitz J; van Veldhuisen D J; Remme W J
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(6):459-65.
2007: Desai Akshay S; Swedberg Karl; McMurray John J V; Granger Christopher B; Yusuf Salim; Young James B; Dunlap Mark E; Solomon Scott D; Hainer James W; Olofsson Bertil; Michelson Eric L; Pfeffer Marc A;
Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.
Journal of the American College of Cardiology 2007;50(20):1959-66.
2007: McMurray John J V; Teerlink John R; Cotter Gadi; Bourge Robert C; Cleland John G F; Jondeau Guillaume; Krum Henry; Metra Marco; O'Connor Christopher M; Parker John D; Torre-Amione Guillermo; van Veldhuisen Dirk J; Lewsey Jim; Frey Aline; Rainisio Maurizio; Kobrin Isaac;
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
JAMA : the journal of the American Medical Association 2007;298(17):2009-19.
2007: Kjekshus John; Apetrei Eduard; Barrios Vivencio; Böhm Michael; Cleland John G F; Cornel Jan H; Dunselman Peter; Fonseca Cândida; Goudev Assen; Grande Peer; Gullestad Lars; Hjalmarson Ake; Hradec Jaromir; Jánosi András; Kamenský Gabriel; Komajda Michel; Korewicki Jerzy; Kuusi Timo; Mach François; Mareev Vyacheslav; McMurray John J V; Ranjith Naresh; Schaufelberger Maria; Vanhaecke Johan; van Veldhuisen Dirk J; Waagstein Finn; Wedel Hans; Wikstrand John;
Rosuvastatin in older patients with systolic heart failure.
The New England journal of medicine 2007;357(22):2248-61.
2007: Seed Alison; Gardner Roy; McMurray John; Hillier Chris; Murdoch David; MacFadyen Robert; Bobillier Alain; Mann Jessica; McDonagh Theresa
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(11):1120-7.
2007: Verma Anil; Anavekar Nagesh S; Meris Alessandra; Thune Jens Jakob; Arnold J Malcolm O; Ghali Jalal K; Velazquez Eric J; McMurray John J V; Pfeffer Marc A; Solomon Scott D
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.
Journal of the American College of Cardiology 2007;50(13):1238-45.
2007: Solomon Scott D; Dobson Joanna; Pocock Stuart; Skali Hicham; McMurray John J V; Granger Christopher B; Yusuf Salim; Swedberg Karl; Young James B; Michelson Eric L; Pfeffer Marc A;
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure.
Circulation 2007;116(13):1482-7.
2007: Balmain Sean; Padmanabhan Neal; Ferrell William R; Morton John J; McMurray John J V
Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(9):865-71.
2007: Kenchaiah Satish; Pocock Stuart J; Wang Duolao; Finn Peter V; Zornoff Leonardo A M; Skali Hicham; Pfeffer Marc A; Yusuf Salim; Swedberg Karl; Michelson Eric L; Granger Christopher B; McMurray John J V; Solomon Scott D;
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;116(6):627-36.
2007: Felker G Michael; Allen Larry A; Pocock Stuart J; Shaw Linda K; McMurray John J V; Pfeffer Marc A; Swedberg Karl; Wang Duolao; Yusuf Salim; Michelson Eric L; Granger Christopher B;
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.
Journal of the American College of Cardiology 2007;50(1):40-7.
2007: Home Philip D; Pocock Stuart J; Beck-Nielsen Henning; Gomis Ramón; Hanefeld Markolf; Jones Nigel P; Komajda Michel; McMurray John J V;
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
The New England journal of medicine 2007;357(1):28-38.
2007: Peacock A J; Murphy N F; McMurray J J V; Caballero L; Stewart S
An epidemiological study of pulmonary arterial hypertension.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007;30(1):104-9.
2007: O'Meara Eileen; Clayton Tim; McEntegart Margaret B; McMurray John J V; Piña Ileana L; Granger Christopher B; Ostergren Jan; Michelson Eric L; Solomon Scott D; Pocock Stuart; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2007;115(24):3111-20.
2007: Metra Marco; Ponikowski Piotr; Dickstein Kenneth; McMurray John J V; Gavazzi Antonello; Bergh Claes-Hakan; Fraser Alan G; Jaarsma Tiny; Pitsis Antonis; Mohacsi Paul; Böhm Michael; Anker Stefan; Dargie Henry; Brutsaert Dirk; Komajda Michel;
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(6-7):684-94.
2007: Murphy Aengus; McMurray John J V
Heart failure: are we neglecting the silent majority?
European heart journal 2007;28(9):1047-8.
2007: Hawkins Nathaniel M; Wang Duolao; McMurray John J V; Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Yusuf Salim; Pocock Stuart J; Ostergren Jan; Michelson Eric L; Dunn Francis G;
Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(5):510-7.
2007: Murphy Niamh F; Simpson Colin R; Jhund Pardeep S; Stewart Simon; Kirkpatrick Michelle; Chalmers Jim; MacIntyre Kate; McMurray John J V
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland.
Heart (British Cardiac Society) 2007;93(5):606-12.
2007: Dargie Henry J; Hildebrandt Per R; Riegger Günter A J; McMurray John J V; McMorn Stephen O; Roberts Jeremy N; Zambanini Andrew; Wilding John P H
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
Journal of the American College of Cardiology 2007;49(16):1696-704.
2007: McEntegart Margaret B; Awede Bonaventure; Petrie Mark C; Sattar Naveed; Dunn Francis G; MacFarlane Niall G; McMurray John J V
Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
European heart journal 2007;28(7):829-35.
2007: Berry Colin; Murphy Niamh F; De Vito Giuseppe; Galloway Stuart; Seed Alison; Fisher Carol; Sattar Naveed; Vallance Patrick; Hillis W Sewart; McMurray John
Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(4):429-34.
2007: Petrie Mark C; McMurray John J V
Dysglycemia and heart failure hospitalization: what is the link?
Circulation 2007;115(11):1334-5.
2007: Stephenson Kent; Skali Hicham; McMurray John J V; Velazquez Eric J; Aylward Philip G; Kober Lars; Van de Werf Frans; White Harvey D; Pieper Karen S; Califf Robert M; Solomon Scott D; Pfeffer Marc A
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):308-13.
2007: Sampson Uchechukwu K; Pfeffer Marc A; McMurray John J V; Lokhnygina Yuliya; White Harvey D; Solomon Scott D;
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.
European heart journal 2007;28(6):685-91.
2007: van Veldhuisen Dirk J; McMurray John J V;
Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(2):110-2.
2007: Amigoni Maria; Meris Alessandra; Thune Jens Jakob; Mangalat Deepa; Skali Hicham; Bourgoun Mikhail; Warnica J Wayne; Barvik Stale; Arnold J Malcolm O; Velazquez Eric J; Van de Werf Frans; Ghali Jalal; McMurray John J V; Køber Lars; Pfeffer Marc A; Solomon Scott D
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
European heart journal 2007;28(3):326-33.
2007: Lewis Eldrin F; Lamas Gervasio A; O'Meara Eileen; Granger Christopher B; Dunlap Mark E; McKelvie Robert S; Probstfield Jeffrey L; Young James B; Michelson Eric L; Halling Katarina; Carlsson Jonas; Olofsson Bertil; McMurray John J V; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(1):83-91.
2007: Hawkins N M; Wang D; McMurray J J V; Pfeffer M A; Swedberg K; Granger C B; Yusuf S; Pocock S J; Ostergren J; Michelson E L; Dunn F G;
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.
Heart (British Cardiac Society) 2007;93(1):59-64.
2006: Weir Robin A P; McMurray John J V
Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction.
Current heart failure reports 2006;3(4):175-80.
2006: Hawkins Nathaniel M; Petrie Mark C; Macdonald Michael R; Hogg Kerry J; McMurray John J V
QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence?
European heart journal 2006;27(24):3074-5; author reply 3075.
2006: Murphy N F; Stewart S; Hart C L; MacIntyre K; Hole D; McMurray J J V
A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew-Paisley study.
Heart (British Cardiac Society) 2006;92(12):1739-46.
2006: Stewart S; Murphy N F; McMurray J J V; Jhund P; Hart C L; Hole D
Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: an analysis of the Renfrew/Paisley Study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(8):856-63.
2006: Capewell S; Murphy N F; MacIntyre K; Frame S; Stewart S; Chalmers J W T; Boyd J; Finlayson A; Redpath A; McMurray J J V
Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study.
Heart (British Cardiac Society) 2006;92(11):1563-70.
2006: Pitt Bertram; Ferrari Roberto; Gheorghiade Mihai; van Veldhuisen Dirk J; Krum Henry; McMurray John; Lopez-Sendon Jose
Aldosterone blockade in post-acute myocardial infarction heart failure.
Clinical cardiology 2006;29(10):434-8.
2006: Valeur Nana; Nielsen Olav Wendelboe; McMurray John J V; Torp-Pedersen Christian; Køber Lars;
Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(6):577-84.
2006: Køber Lars; Swedberg Karl; McMurray John J V; Pfeffer Marc A; Velazquez Eric J; Diaz Rafael; Maggioni Aldo P; Mareev Viatcheslav; Opolski Grzegorz; Van de Werf Frans; Zannad Faiez; Ertl Georg; Solomon Scott D; Zelenkofske Steven; Rouleau Jean-Lucien; Leimberger Jeffrey D; Califf Robert M
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(6):591-8.
2006: Solomon Scott D; Pfeffer Marc A; McMurray John J V; Fowler Rob; Finn Peter; Levin Bernard; Eagle Craig; Hawk Ernest; Lechuga Mariajosé; Zauber Ann G; Bertagnolli Monica M; Arber Nadir; Wittes Janet;
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.
Circulation 2006;114(10):1028-35.
2006: Reed Shelby D; McMurray John J V; Velazquez Eric J; Schulman Kevin A; Califf Robert M; Kober Lars; Maggioni Aldo P; Van de Werf Frans; White Harvey D; Diaz Rafael; Mareev Viatcheslav; Murin Jan;
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Granger Christopher B; McMurray John J V
Using measures of disease progression to determine therapeutic effect: a sirens' song.
Journal of the American College of Cardiology 2006;48(3):434-7.
2006: McMurray John; Swedberg Karl
Treatment of chronic heart failure: a comparison between the major guidelines.
European heart journal 2006;27(15):1773-7.
2006: Murphy N F; Simpson C R; MacIntyre K; McAlister F A; Chalmers J; McMurray J J V
Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study.
Heart (British Cardiac Society) 2006;92(8):1047-54.
2006: Ducharme Anique; Swedberg Karl; Pfeffer Marc A; Cohen-Solal Alain; Granger Christopher B; Maggioni Aldo P; Michelson Eric L; McMurray John J V; Olsson Lars; Rouleau Jean L; Young James B; Olofsson Bertil; Puu Margareta; Yusuf Salim;
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;152(1):86-92.
2006: Janardhanan Rajesh; Kenchaiah Satish; Velazquez Eric J; Park Yuhyun; McMurray John J V; Weaver W Douglas; Finn Peter V; White Harvey D; Marin-Neto Jose A; O'Connor Chris; Pfeffer Marc A; Califf Robert M; Solomon Scott D;
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
American heart journal 2006;152(1):183-9.
2006: Hogg Karen; McMurray John
The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").
Heart failure reviews 2006;11(2):141-6.
2006: Berry Colin; Norrie John; Hogg Karen; Brett Michael; Stevenson Karen; McMurray John J V
The prevalence, nature, and importance of hematologic abnormalities in heart failure.
American heart journal 2006;151(6):1313-21.
2006: Jhund Pardeep; McMurray John J V
Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? Choosing between the Scylla of observational studies and the Charybdis of subgroup analysis.
Circulation 2006;113(22):2566-8.
2006: McMurray John J V; Andersson Fredrik L; Stewart Simon; Svensson Klas; Solal Alain Cohen; Dietz Rainer; Vanhaecke Johan; van Veldhuisen Dirk J; Ostergren Jan; Granger Christopher B; Yusuf Salim; Pfeffer Marc A; Swedberg Karl
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2006;27(12):1447-58.
2006: Hawkins Nathaniel M; Petrie Mark C; MacDonald Michael R; Hogg Kerry J; McMurray John J V
Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?
European heart journal 2006;27(11):1270-81.
2006: Weir Robin A P; McMurray John J V; Velazquez Eric J
Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.
The American journal of cardiology 2006;97(10A):13F-25F.
2006: Olsson Lars G; Swedberg Karl; Ducharme Anique; Granger Christopher B; Michelson Eric L; McMurray John J V; Puu Margareta; Yusuf Salim; Pfeffer Marc A;
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Journal of the American College of Cardiology 2006;47(10):1997-2004.
2006: McMurray John J V; Young James B; Dunlap Mark E; Granger Christopher B; Hainer James; Michelson Eric L; Earle Steven; Olofsson Bertil; Ostergren Jan; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
American heart journal 2006;151(5):985-91.
2006: Ducharme Anique; Swedberg Karl; Pfeffer Marc A; Cohen-Solal Alain; Granger Christopher B; Maggioni Aldo P; Michelson Eric L; McMurray John J V; Olsson Lars; Rouleau Jean L; Young James B; Yusuf Salim
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
American heart journal 2006;151(5):985-91.
2006: MacIntyre K; Murphy N F; Chalmers J; Capewell S; Frame S; Finlayson A; Pell J; Redpath A; McMurray J J V
Hospital burden of suspected acute coronary syndromes: recent trends.
Heart (British Cardiac Society) 2006;92(5):691-2.
2006: Walker A; McMurray J; Stewart S; Berger W; McMahon A D; Dargie H; Fox K; Hillis S; Henderson N J K; Ford I
Economic evaluation of the impact of nicorandil in angina (IONA) trial.
Heart (British Cardiac Society) 2006;92(5):619-24.
2006: Capewell S; Unal B; Critchley J A; McMurray J J V
Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.
Heart (British Cardiac Society) 2006;92(4):521-3.
2006: Stewart Simon; McMurray John J V
Chilling findings: the need for winter vigilance in heart failure.
Journal of cardiac failure 2006;12(2):120-1.
2006: Stewart Simon; Wilkinson David; Becker Anthony; Askew Deborah; Ntyintyane Lucas; McMurray John J V; Sliwa Karen
Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study.
International journal of cardiology 2006;108(1):101-8.
2006: McMurray John J V
Drug safety in cardiovascular disease: a call to ACTION.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(1):9-10.
2006: McMurray John; Solomon Scott; Pieper Karen; Reed Shelby; Rouleau Jean; Velazquez Eric; White Harvey; Howlett Jonathan; Swedberg Karl; Maggioni Aldo; Køber Lars; Van de Werf Frans; Califf Rob; Pfeffer Marc
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Journal of the American College of Cardiology 2006;47(4):726-33.
2006: O'Meara Eileen; Clayton Tim; McEntegart Margaret B; McMurray John J V; Lang Chim C; Roger Simon D; Young James B; Solomon Scott D; Granger Christopher B; Ostergren Jan; Olofsson Bertil; Michelson Eric L; Pocock Stuart; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
Circulation 2006;113(7):986-94.
2006: Hillege Hans L; Nitsch Dorothea; Pfeffer Marc A; Swedberg Karl; McMurray John J V; Yusuf Salim; Granger Christopher B; Michelson Eric L; Ostergren Jan; Cornel Jan Hein; de Zeeuw Dick; Pocock Stuart; van Veldhuisen Dirk J;
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: Kauf Teresa L; Velazquez Eric J; Crosslin David R; Weaver W Douglas; Diaz Rafael; Granger Christopher B; McMurray John J V; Rouleau Jean-Lucien; Aylward Philip E; White Harvey D; Califf Robert M; Schulman Kevin A
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2006: Pocock Stuart J; Wang Duolao; Pfeffer Marc A; Yusuf Salim; McMurray John J V; Swedberg Karl B; Ostergren Jan; Michelson Eric L; Pieper Karen S; Granger Christopher B
Predictors of mortality and morbidity in patients with chronic heart failure.
European heart journal 2006;27(1):65-75.
2006: Murphy N F; MacIntyre K; Stewart S; Hart C L; Hole D; McMurray J J V
Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study).
European heart journal 2006;27(1):96-106.
2005: Clark Alexander M; McMurray John J V; Morrison Caroline E; Murdoch David L; Capewell Simon; Reid Margaret E
A qualitative study of the contribution of pharmacists to heart failure management in Scotland.
Pharmacy world & science : PWS 2005;27(6):453-8.
2005: Granger Bradi B; Swedberg Karl; Ekman Inger; Granger Christopher B; Olofsson Bertil; McMurray John J V; Yusuf Salim; Michelson Eric L; Pfeffer Marc A;
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.
Lancet 2005;366(9502):2005-11.
2005: Solomon Scott D; Anavekar Nagesh; Skali Hicham; McMurray John J V; Swedberg Karl; Yusuf Salim; Granger Christopher B; Michelson Eric L; Wang Duolao; Pocock Stuart; Pfeffer Marc A;
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.
Circulation 2005;112(24):3738-44.
2005: White Harvey D; Aylward Philip E G; Huang Zhen; Dalby Anthony J; Weaver W Douglas; Barvik Ståle; Marin-Neto José Antonio; Murin Jan; Nordlander Rolf O; van Gilst Wiek H; Zannad Faiez; McMurray John J V; Califf Robert M; Pfeffer Marc A;
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Remme Willem J; McMurray John J V; Rauch Bernhard; Zannad Faiez; Keukelaar Karen; Cohen-Solal Alain; Lopez-Sendon José; Hobbs F D Richard; Grobbee Diederick E; Boccanelli Alessandro; Cline Charles; Macarie Cezar; Dietz Rainer; Ruzyllo Witold
Public awareness of heart failure in Europe: first results from SHAPE.
European heart journal 2005;26(22):2413-21.
2005: Demers Catherine; McMurray John J V; Swedberg Karl; Pfeffer Marc A; Granger Christopher B; Olofsson Bertil; McKelvie Robert S; Ostergren Jan; Michelson Eric L; Johansson Peter A; Wang Duolao; Yusuf Salim;
Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
JAMA : the journal of the American Medical Association 2005;294(14):1794-8.
2005: McMurray John J V
Chronic kidney disease in patients with cardiac disease: a review of evidence-based treatment.
Kidney international 2005;68(4):1419-26.
2005: MacIntrye Iain M; Jhund Pardeep S; McMurray John J V
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(4):261-5.
2005: McMurray John; Cohen-Solal Alain; Dietz Rainer; Eichhorn Eric; Erhardt Leif; Hobbs F D Richard; Krum Henry; Maggioni Aldo; McKelvie Robert S; Piña Ileana L; Soler-Soler Jordi; Swedberg Karl
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):710-21.
2005: Reed Shelby D; Radeva Jasmina I; Weinfurt Kevin P; McMurray John J V; Pfeffer Marc A; Velazquez Eric J; Allsbrook Jennifer S; Masselink Leah E; Sellers Mary Ann; Califf Robert M; Schulman Kevin A;
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
American heart journal 2005;150(2):323-9.
2005: Teerlink John R; McMurray John J V; Bourge Robert C; Cleland John G F; Cotter Gadi; Jondeau Guillaume; Krum Henry; Metra Marco; O'Connor Christopher M; Parker John D; Torre-Amione Guillermo; Van Veldhuisen Dirk J; Frey Aline; Rainisio Maurizio; Kobrin Isaac;
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
American heart journal 2005;150(1):46-53.
2005: Berry C; Hogg K; Norrie J; Stevenson K; Brett M; McMurray J
Heart failure with preserved left ventricular systolic function: a hospital cohort study.
Heart (British Cardiac Society) 2005;91(7):907-13.
2005: Solomon Scott D; Zelenkofske Steve; McMurray John J V; Finn Peter V; Velazquez Eric; Ertl George; Harsanyi Adam; Rouleau Jean L; Maggioni Aldo; Kober Lars; White Harvey; Van de Werf Frans; Pieper Karen; Califf Robert M; Pfeffer Marc A;
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
The New England journal of medicine 2005;352(25):2581-8.
2005: Stewart Simon; McAlister Finlay A; McMurray John J V
Heart failure management programs reduce readmissions and prolong survival.
Archives of internal medicine 2005;165(11):1311; author reply 1311-2.
2005: O'Meara Eileen; Lewis Eldrin; Granger Chris; Dunlap Mark E; McKelvie Robert S; Probstfield Jeffrey L; Young James B; Michelson Eric L; Ostergren Jan; Carlsson Jonas; Olofsson Bertil; McMurray John; Yusuf Salim; Swedberg Karl; Pfeffer Marc A
Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(4):650-6.
2005: Murphy N F; MacIntyre K; Stewart S; Capewell S; McMurray J J V
Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care?
Heart (British Cardiac Society) 2005;91(6):726-30.
2005: Hogg Karen; McMurray John
Neurohumoral pathways in heart failure with preserved systolic function.
Progress in cardiovascular diseases 2005;47(6):357-66.
2005: McMurray John J V; Pfeffer Marc A
Heart failure.
Lancet 2005;365(9474):1877-89.
2005: Weir R; McMurray J J V
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Heart (British Cardiac Society) 2005;91 Suppl 2():ii17-20; discussion ii31, ii43-8.
2005: Stewart Simon; McMurray John J V; Hebborn Ansgar; Coats Andrew J S; Packer Milton;
Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
International journal of cardiology 2005;100(1):143-9.
2005: McMurray John J V
Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?
Nature clinical practice. Cardiovascular medicine 2005;2(3):128-9.
2005: Berry Colin; Norrie John; McMurray John J V
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(2):149-51.
2005: Mix T-Christian H; Brenner Robert M; Cooper Mark E; de Zeeuw Dick; Ivanovich Peter; Levey Andrew S; McGill Janet B; McMurray John J V; Parfrey Patrick S; Parving Hans-Henrik; Pereira Brian J G; Remuzzi Giuseppe; Singh Ajay K; Solomon Scott D; Stehman-Breen Catherine; Toto Robert D; Pfeffer Marc A
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
American heart journal 2005;149(3):408-13.
2005: Blue Lynda; McMurray J
How much responsibility should heart failure nurses take?
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(3):351-61.
2005: Solomon Scott D; McMurray John J V; Pfeffer Marc A; Wittes Janet; Fowler Robert; Finn Peter; Anderson William F; Zauber Ann; Hawk Ernest; Bertagnolli Monica;
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
The New England journal of medicine 2005;352(11):1071-80.
2005: McMurray John; Køber Lars; Robertson Michele; Dargie Henry; Colucci Wilson; Lopez-Sendon Jose; Remme Willem; Sharpe D Norman; Ford Ian
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
Journal of the American College of Cardiology 2005;45(4):525-30.
2005: O'Meara E; McMurray J J V
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
Heart (British Cardiac Society) 2005;91(2):131-2.
2005: Pfeffer Marc A; Solomon Scott D; Singh Ajay K; Ivanovich Peter; McMurray John J V
Uncertainty in the treatment of anemia in chronic kidney disease.
Reviews in cardiovascular medicine 2005;6 Suppl 3():S35-41.
2004: O'Meara Eileen; Murphy Clare; McMurray John J V
Anemia and heart failure.
Current heart failure reports 2004;1(4):176-82.
2004: McMurray John J V; Pfeffer Marc A
The year in heart failure.
Journal of the American College of Cardiology 2004;44(12):2398-405.
2004: McMurray John J V; Pfeffer Marc A; Swedberg Karl; Dzau Victor J
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
Circulation 2004;110(20):3281-8.
2004: O'Meara Eileen; Solomon Scott; McMurray John; Pfeffer Marc; Yusuf Salim; Michelson Eric; Granger Chris; Olofsson Bertil; Young James B; Swedberg Karl
Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2004;25(21):1920-6.
2004: Velazquez Eric J; Francis Gary S; Armstrong Paul W; Aylward Phillip E; Diaz Rafael; O'Connor Christopher M; White Harvey D; Henis Marc; Rittenhouse Lois M; Kilaru Rakhi; van Gilst Wiek; Ertl Georg; Maggioni Aldo P; Spac Jiri; Weaver W Douglas; Rouleau Jean-Lucien; McMurray John J V; Pfeffer Marc A; Califf Robert M;
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Murphy Niamh F; Stewart Simon; MacIntyre Kate; Capewell Simon; McMurray John J V
Seasonal variation in morbidity and mortality related to atrial fibrillation.
International journal of cardiology 2004;97(2):283-8.
2004: Young James B; Dunlap Mark E; Pfeffer Marc A; Probstfield Jeffrey L; Cohen-Solal Alain; Dietz Rainer; Granger Christopher B; Hradec Jaromir; Kuch Jerzy; McKelvie Robert S; McMurray John J V; Michelson Eric L; Olofsson Bertil; Ostergren Jan; Held Peter; Solomon Scott D; Yusuf Salim; Swedberg Karl;
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Circulation 2004;110(17):2618-26.
2004: Solomon Scott D; Wang Duolao; Finn Peter; Skali Hicham; Zornoff Leonardo; McMurray John J V; Swedberg Karl; Yusuf Salim; Granger Christopher B; Michelson Eric L; Pocock Stuart; Pfeffer Marc A
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program.
Circulation 2004;110(15):2180-3.
2004: Murphy N F; Simpson C R; McAlister F A; Stewart S; MacIntyre K; Kirkpatrick M; Chalmers J; Redpath A; Capewell S; McMurray J J V
National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland.
Heart (British Cardiac Society) 2004;90(10):1129-36.
2004: McMurray John J V
Angiotensin inhibition in heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5 Suppl 1():S17-22.
2004: Bunton David C; Petrie Mark C; Hillier Chris; Johnston Fiona; McMurray John J V
The clinical relevance of adrenomedullin: a promising profile?
Pharmacology & therapeutics 2004;103(3):179-201.
2004: Anavekar Nagesh S; McMurray John J V; Velazquez Eric J; Solomon Scott D; Kober Lars; Rouleau Jean-Lucien; White Harvey D; Nordlander Rolf; Maggioni Aldo; Dickstein Kenneth; Zelenkofske Steven; Leimberger Jeffrey D; Califf Robert M; Pfeffer Marc A
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
The New England journal of medicine 2004;351(13):1285-95.
2004: Aguilar David; Solomon Scott D; Køber Lars; Rouleau Jean-Lucien; Skali Hicham; McMurray John J V; Francis Gary S; Henis Marc; O'Connor Christopher M; Diaz Rafael; Belenkov Yuri N; Varshavsky Sergei; Leimberger Jeffrey D; Velazquez Eric J; Califf Robert M; Pfeffer Marc A
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Circulation 2004;110(12):1572-8.
2004: McMurray John J V; O'Meara Eileen
Treatment of heart failure with spironolactone--trial and tribulations.
The New England journal of medicine 2004;351(6):526-8.
2004: Anand Inder; McMurray John J V; Whitmore James; Warren Marshelle; Pham Anh; McCamish Mark A; Burton Paul B J
Anemia and its relationship to clinical outcome in heart failure.
Circulation 2004;110(2):149-54.
2004: Meredith Peter A; Murray Lilian S; McMurray John J V;
A putative placebo comparison of the SCOPE and LIFE trials.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(2):59-63.
2004: Riegel Barbara; Naylor Mary; Stewart Simon; McMurray John J V; Rich Michael W
Interventions to prevent readmission for congestive heart failure.
JAMA : the journal of the American Medical Association 2004;291(23):2816; author reply 2816-7.
2004: Murphy N F; MacIntyre K; Capewell S; Stewart S; Pell J; Chalmers J; Redpath A; Frame S; Boyd J; McMurray J J V
Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis.
BMJ (Clinical research ed.) 2004;328(7453):1413-4.
2004: McAlister F A; Murphy N F; Simpson C R; Stewart S; MacIntyre K; Kirkpatrick M; Chalmers J; Redpath A; Capewell S; McMurray J J V
Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study.
BMJ (Clinical research ed.) 2004;328(7448):1110.
2004: Petrie M C; Hogg K; Caruana L; McMurray J J V
Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?
Heart (British Cardiac Society) 2004;90(5):511-7.
2004: Hood William B; Dans Antonio L; Guyatt Gordon H; Jaeschke Roman; McMurray John J V
Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis.
Journal of cardiac failure 2004;10(2):155-64.
2004: Mann Douglas L; McMurray John J V; Packer Milton; Swedberg Karl; Borer Jeffrey S; Colucci Wilson S; Djian Jacques; Drexler Helmut; Feldman Arthur; Kober Lars; Krum Henry; Liu Peter; Nieminen Markku; Tavazzi Luigi; van Veldhuisen Dirk Jan; Waldenstrom Anders; Warren Marshelle; Westheim Arne; Zannad Faiez; Fleming Thomas
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
Circulation 2004;109(13):1594-602.
2004: Swedberg Karl; McMurray John J V
Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
European heart journal 2004;25(5):357-8.
2004: Stewart S; Murphy N F; Walker A; McGuire A; McMurray J J V
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.
Heart (British Cardiac Society) 2004;90(3):286-92.
2004: Hogg Karen; Swedberg Karl; McMurray John
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.
Journal of the American College of Cardiology 2004;43(3):317-27.
2004: McMurray John J V
What are the clinical consequences of anemia in patients with chronic heart failure?
Journal of cardiac failure 2004;10(1 Suppl):S10-2.
2004: Jhund Pardeep S; Dawson Nuala; Davie Andrew P; Norrie John; O'Kane Kevin P J; McMurray John J V
17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(1):31-6.
2004: Hood W B; Dans A L; Guyatt G H; Jaeschke R; McMurray J J V
Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
Cochrane database of systematic reviews (Online) 2004;(2):CD002901.
2003: Pfeffer Marc A; McMurray John J V; Velazquez Eric J; Rouleau Jean-Lucien; Køber Lars; Maggioni Aldo P; Solomon Scott D; Swedberg Karl; Van de Werf Frans; White Harvey; Leimberger Jeffrey D; Henis Marc; Edwards Susan; Zelenkofske Steven; Sellers Mary Ann; Califf Robert M;
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
The New England journal of medicine 2003;349(20):1893-906.
2003: Stergren Jan; McMurray John J V
Angiotensin receptor blockers in heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(3):171-5.
2003: Yusuf Salim; Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Held Peter; McMurray John J V; Michelson Eric L; Olofsson Bertil; Ostergren Jan;
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Lancet 2003;362(9386):777-81.
2003: Granger Christopher B; McMurray John J V; Yusuf Salim; Held Peter; Michelson Eric L; Olofsson Bertil; Ostergren Jan; Pfeffer Marc A; Swedberg Karl;
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet 2003;362(9386):772-6.
2003: McMurray John J V; Ostergren Jan; Swedberg Karl; Granger Christopher B; Held Peter; Michelson Eric L; Olofsson Bertil; Yusuf Salim; Pfeffer Marc A;
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
Lancet 2003;362(9386):767-71.
2003: Pfeffer Marc A; Swedberg Karl; Granger Christopher B; Held Peter; McMurray John J V; Michelson Eric L; Olofsson Bertil; Ostergren Jan; Yusuf Salim; Pocock Stuart;
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Lancet 2003;362(9386):759-66.
2003: McMurray John J V; Hillier Chris
The rise and fall of myotrophin in heart failure.
Journal of the American College of Cardiology 2003;42(4):726-7.
2003: Fisher C; Berry C; Blue L; Morton J J; McMurray J
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.
Heart (British Cardiac Society) 2003;89(8):879-81.
2003: Stewart S; Murphy N F; Walker A; McGuire A; McMurray J J V
The current cost of angina pectoris to the National Health Service in the UK.
Heart (British Cardiac Society) 2003;89(8):848-53.
2003: Fisher C; Al-Benna S; Kirk A; Morton J J; McMurray J J V
Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin.
Heart (British Cardiac Society) 2003;89(7):789-90.
2003: McMurray J; Ostergren J; Pfeffer M; Swedberg K; Granger C; Yusuf S; Held P; Michelson E; Olofsson B;
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(3):261-70.
2003: Stewart S; MacIntyre K; Capewell S; McMurray J J V
Heart failure and the aging population: an increasing burden in the 21st century?
Heart (British Cardiac Society) 2003;89(1):49-53.
2002: Stewart Simon; Hart Carole L; Hole David J; McMurray John J V
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.
The American journal of medicine 2002;113(5):359-64.
2002: Stewart Simon; McMurray John J V
Palliative care for heart failure.
BMJ (Clinical research ed.) 2002;325(7370):915-6.
2002: McMurray J J V
Heart failure in 10 years time: focus on pharmacological treatment.
Heart (British Cardiac Society) 2002;88 Suppl 2():ii40-6.
2002: Stewart S; Blue L; Walker A; Morrison C; McMurray J J V
An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?
European heart journal 2002;23(17):1369-78.
2002: Fisher Carol; MacLean Margaret; Morecroft Ian; Seed Alison; Johnston Fiona; Hillier Christopher; McMurray John
Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart?
Circulation 2002;106(3):292-5.
2002: Fisher Carol; McMurray John J V
Current management of heart failure.
The Practitioner 2002;246(1635):438-43.
2002: Pfeffer Marc A; McMurray John J V
Myocardial infarct: no one size fits all.
Circulation 2002;105(22):2577-9.
2002: McMurray John; Pfeffer Marc A
New therapeutic options in congestive heart failure: Part II.
Circulation 2002;105(18):2223-8.
2002: McMurray John; Pfeffer Marc A
New therapeutic options in congestive heart failure: Part I.
Circulation 2002;105(17):2099-106.
2002: Stewart S; Demers C; Murdoch D R; McIntyre K; MacLeod M E; Kendrick S; Capewell S; McMurray J J V
Substantial between-hospital variation in outcome following first emergency admission for heart failure.
European heart journal 2002;23(8):650-7.
2002: Stewart S; MacIntyre K; Chalmers J W T; Boyd J; Finlayson A; Redpath A; Pell J P; Capewell S; McMurray J J V
Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995.
International journal of cardiology 2002;82(3):229-36.
2002: Stewart Simon; McIntyre Kate; Capewell Simon; McMurray John J V
Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality.
Journal of the American College of Cardiology 2002;39(5):760-6.
2002: De Vito G; Galloway S D R; Nimmo M A; Maas P; McMurray J J V
Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans.
Clinical physiology and functional imaging 2002;22(1):32-8.
2002: Davie Andrew P; McMurray John J V
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.
British journal of clinical pharmacology 2002;53(1):37-42.
2002: Pell J P; MacIntyre K; Walsh D; Capewell S; McMurray J J V; Chalmers J W T; Boyd J H; Finlayson A R; Stewart S; Redpath A D
Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study.
BMJ (Clinical research ed.) 2002;324(7331):201-2.
2002: Petrie M C; Caruana L; Berry C; McMurray J J V
"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction?
Heart (British Cardiac Society) 2002;87(1):29-31.
2002: Davie A P; McMurray J J V
Cost effectiveness of invasive strategy in unstable coronary disease--what are we waiting for?
European heart journal 2002;23(1):1-3.
2001: Berry C; Stewart S; Payne E M; McArthur J D; McMurray J J
Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice.
International journal of cardiology 2001;81(1):29-35.
2001: Petrie M C; Berry C; Stewart S; McMurray J J
Failing ageing hearts.
European heart journal 2001;22(21):1978-90.
2001: Stewart S; Hart C L; Hole D J; McMurray J J
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.
Heart (British Cardiac Society) 2001;86(5):516-21.
2001: Capewell S; MacIntyre K; Stewart S; Chalmers J W; Boyd J; Finlayson A; Redpath A; Pell J P; McMurray J J
Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study.
Lancet 2001;358(9289):1213-7.
2001: McDonald J E; Padmanabhan N; Petrie M C; Hillier C; Connell J M; McMurray J J
Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans.
Circulation 2001;104(15):1805-8.
2001: Blue L; Lang E; McMurray J J; Davie A P; McDonagh T A; Murdoch D R; Petrie M C; Connolly E; Norrie J; Round C E; Ford I; Morrison C E
Randomised controlled trial of specialist nurse intervention in heart failure.
BMJ (Clinical research ed.) 2001;323(7315):715-8.
2001: Petrie M C; Hillier C; Johnston F; McMurray J J
Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure.
Hypertension 2001;38(3):412-6.
2001: Morris S T; McMurray J J; Spiers A; Jardine A G
Impaired endothelial function in isolated human uremic resistance arteries.
Kidney international 2001;60(3):1077-82.
2001: MacIntyre K; Stewart S; Capewell S; Chalmers J W; Pell J P; Boyd J; Finlayson A; Redpath A; Gilmour H; McMurray J J
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction.
Journal of the American College of Cardiology 2001;38(3):729-35.
2001: McMurray J; Cohen-Solal A; Dietz R; Eichhorn E; Erhardt L; Hobbs R; Maggioni A; Pina I; Soler-Soler J; Swedberg K;
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(4):495-502.
2001: Petrie M C; McDonald J E; Hillier C; Morton J J; McMurray J J
Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans.
British journal of clinical pharmacology 2001;52(2):165-8.
2001: McMurray J J
Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
Heart (British Cardiac Society) 2001;86(1):97-103.
2001: McDonagh T A; Cunningham A D; Morrison C E; McMurray J J; Ford I; Morton J J; Dargie H J
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.
Heart (British Cardiac Society) 2001;86(1):21-6.
2001: Hillier C; Petrie M C; Love M P; Johnston F; MacLean M R; McMurray J J
Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure.
Clinical science (London, England : 1979) 2001;101(1):45-51.
2001: McMurray J J
Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2001;2(2):89-92.
2001: Stewart S; MacIntyre K; Hole D J; Capewell S; McMurray J J
More 'malignant' than cancer? Five-year survival following a first admission for heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(3):315-22.
2001: Berry C; Murdoch D R; McMurray J J
Economics of chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(3):283-91.
2001: Seed A; McMurray J
Acute endothelin a receptor blockade in heart failure.
Circulation 2001;103(18):E94-4.
2001: Murdoch D R; McDonagh T A; Farmer R; Morton J J; McMurray J J; Dargie H J
ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
American heart journal 2001;141(5):800-7.
2001: Jhund P S; Dawson N; Davie A P; Sattar N; Norrie J; O'Kane K P; McMurray J J
Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease.
Journal of the American College of Cardiology 2001;37(5):1367-73.
2001: Jhund P S; Davie A P; McMurray J J
Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure.
Journal of the American College of Cardiology 2001;37(5):1234-8.
2001: Stewart S; MacIntyre K; MacLeod M M; Bailey A E; Capewell S; McMurray J J
Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996.
European heart journal 2001;22(8):693-701.
2001: Berry C; McMurray J J
Serious adverse events experienced by patients with chronic heart failure taking spironolactone.
Heart (British Cardiac Society) 2001;85(4):E8.
2001: Coats P; Johnston F; MacDonald J; McMurray J J; Hillier C
Endothelium-derived hyperpolarizing factor : identification and mechanisms of action in human subcutaneous resistance arteries.
Circulation 2001;103(12):1702-8.
2001: Petrie M C; Padmanabhan N; McDonald J E; Hillier C; Connell J M; McMurray J J
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Journal of the American College of Cardiology 2001;37(4):1056-61.
2001: Stewart S; Blue L; Capewell S; Horowitz J D; McMurray J J
Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(2):249-55.
2001: Caruana L; Petrie M C; McMurray J J; MacFarlane N G
Altered diaphragm position and function in patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(2):183-7.
2001: Hillier C; Berry C; Petrie M C; O'Dwyer P J; Hamilton C; Brown A; McMurray J
Effects of urotensin II in human arteries and veins of varying caliber.
Circulation 2001;103(10):1378-81.
2001: Coats P; Johnston F; MacDonald J; McMurray J J; Hillier C
Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries.
Cardiovascular research 2001;49(4):828-37.
2001: Stewart S; MacIntyre K; MacLeod M M; Bailey A E; Capewell S; McMurray J J
Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?
European heart journal 2001;22(3):209-17.
2000: Capewell S; Livingston B M; MacIntyre K; Chalmers J W; Boyd J; Finlayson A; Redpath A; Pell J P; Evans C J; McMurray J J
Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland.
European heart journal 2000;21(22):1833-40.
2000: Galloway S D; De Vito G; McClure S; Nimmo M A; McMurray J J
Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans.
Clinical science (London, England : 1979) 2000;99(3):223-30.
2000: MacIntyre K; Capewell S; Stewart S; Chalmers J W; Boyd J; Finlayson A; Redpath A; Pell J P; McMurray J J
Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995.
Circulation 2000;102(10):1126-31.
2000: McMurray J
AT(1) receptor antagonists-beyond blood pressure control: possible place in heart failure treatment.
Heart (British Cardiac Society) 2000;84 Suppl 1():i42-5: discussion i50.
2000: Morris S T; McMurray J J; Rodger R S; Jardine A G
Impaired endothelium-dependent vasodilatation in uraemia.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(8):1194-200.
2000: Caruana L; Petrie M C; Davie A P; McMurray J J
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study.
BMJ (Clinical research ed.) 2000;321(7255):215-8.
2000: Jhund P S; McMurray J J; Davie A P
The acute vascular effects of frusemide in heart failure.
British journal of clinical pharmacology 2000;50(1):9-13.
2000: Davie A P; Love M P; McMurray J J
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure.
Clinical pharmacology and therapeutics 2000;67(5):530-7.
2000: Berry C; Hamilton C A; Brosnan M J; Magill F G; Berg G A; McMurray J J; Dominiczak A F
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries.
Circulation 2000;101(18):2206-12.
2000: McMurray J J; Stewart S
Epidemiology, aetiology, and prognosis of heart failure.
Heart (British Cardiac Society) 2000;83(5):596-602.
2000: Granger C B; Ertl G; Kuch J; Maggioni A P; McMurray J; Rouleau J L; Stevenson L W; Swedberg K; Young J; Yusuf S; Califf R M; Bart B A; Held P; Michelson E L; Sellers M A; Ohlin G; Sparapani R; Pfeffer M A
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
American heart journal 2000;139(4):609-17.
2000: Morris S T; McMurray J J; Rodger R S; Farmer R; Jardine A G
Endothelial dysfunction in renal transplant recipients maintained on cyclosporine.
Kidney international 2000;57(3):1100-6.
2000: Petrie M C; Hillier C; Morton J J; McMurray J J
Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans.
Journal of hypertension 2000;18(1):61-4.
2000: Love M P; Haynes W G; Webb D J; McMurray J J
Venous endothelin receptor function in patients with chronic heart failure.
Clinical science (London, England : 1979) 2000;98(1):65-70.
1999: Hillier C; Cowburn P J; Morton J J; Dargie H J; Cleland J G; McMurray J J; McGrath J C
Structural and functional assessment of small arteries in patients with chronic heart failure.
Clinical science (London, England : 1979) 1999;97(6):671-9.
1999: Murdoch D R; McMurray J J
Cardiac cachexia--lean and mean.
European heart journal 1999;20(22):1609-11.
1999: Capewell S; Pell J P; Morrison C; McMurray J
Increasing the impact of cardiological treatments. How best to reduce deaths.
European heart journal 1999;20(19):1386-92.
1999: Swedberg K; Pfeffer M; Granger C; Held P; McMurray J; Ohlin G; Olofsson B; Ostergren J; Yusuf S
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
Journal of cardiac failure 1999;5(3):276-82.
1999: Davie A P; McMurray J J
Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor.
Hypertension 1999;34(3):457-60.
1999: Murdoch D R; Rooney E; Dargie H J; Shapiro D; Morton J J; McMurray J J
Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.
Heart (British Cardiac Society) 1999;82(3):352-6.
1999: Darnley G M; Gray A C; McClure S J; Neary P; Petrie M; McMurray J J; MacFarlane N G
Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 1999;1(3):297-300.
1999: Bart B A; Ertl G; Held P; Kuch J; Maggioni A P; McMurray J; Michelson E L; Rouleau J L; Warner Stevenson L; Swedberg K; Young J B; Yusuf S; Sellers M A; Granger C B; Califf R M; Pfeffer M A
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
European heart journal 1999;20(16):1182-90.
1999: Davie A P; Dargie H J; McMurray J J
Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
Circulation 1999;100(3):268-73.
1999: Petrie M C; Dawson N F; Murdoch D R; Davie A P; McMurray J J
Failure of women's hearts.
Circulation 1999;99(17):2334-41.
1999: Davie A P; McMurray J J
ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?
Postgraduate medical journal 1999;75(882):219-2.
1999: Capewell S; Morrison C E; McMurray J J
Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
Heart (British Cardiac Society) 1999;81(4):380-6.
1999: Northridge D B; Currie P F; Newby D E; McMurray J J; Ford M; Boon N A; Dargie H J
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 1999;1(1):67-72.
1999: Caruana L; Davie A P; Petrie M; McMurray J
Diagnosing heart failure.
European heart journal 1999;20(5):393.
1999: Davie A P; Morrison C E; Forrester J E; Mcmurray J J
Prescribing and emergency admissions for heart failure in greater Glasgow.
Journal of cardiac failure 1999;5(1):3-7.
1999: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; McMurray J J; Dargie H J; Morton J J
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction.
Journal of the American College of Cardiology 1999;33(4):932-8.
1999: Bonnar C E; Davie A P; Caruana L; Fenn L; Ogston S A; McMurray J J; Struthers A D
QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion.
Heart (British Cardiac Society) 1999;81(3):297-302.
1999: Morris S T; McMurray J J; Rodger R S; Briggs J D; Jardine A G
Impaired vascular responsiveness to nitric oxide in renal transplant recipients.
Transplantation proceedings 1999;31(1-2):304-5.
1998: Murdoch D R; Love M P; Robb S D; McDonagh T A; Davie A P; Ford I; Capewell S; Morrison C E; McMurray J J
Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992.
European heart journal 1998;19(12):1829-35.
1998: McMurray J J
Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
European heart journal 1998;19 Suppl L():L15-21.
1998: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; Dargie H J; McMurray J J; Morton J J
Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.
Cardiovascular research 1998;39(3):563-70.
1998: McClure S J; Caruana L; Davie A P; Goldthorp S; McMurray J J
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.
BMJ (Clinical research ed.) 1998;317(7157):516-9.
1998: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; McMurray J J; Dargie H J
Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure.
Lancet 1998;352(9123):201-2.
1998: Davie A P; Caesar D; Caruana L; Clegg G; Spiller J; Capewell S; Starkey I R; Shaw T R; McMurray J J
Outcome from a rapid-assessment chest pain clinic.
QJM : monthly journal of the Association of Physicians 1998;91(5):339-43.
1998: Grant S; McMurray J; Aitchison T; McDonagh T; Christie J; Davie A; Dargie H J
The reproducibility of symptoms during a submaximal exercise test in chronic heart failure.
British journal of clinical pharmacology 1998;45(3):287-90.
1998: McDonagh T A; Robb S D; Murdoch D R; Morton J J; Ford I; Morrison C E; Tunstall-Pedoe H; McMurray J J; Dargie H J
Biochemical detection of left-ventricular systolic dysfunction.
Lancet 1998;351(9095):9-13.
1998: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; McMurray J J; Dargie H J
Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunction.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S290-3.
1997: Murdoch D R; Byrne J; Morton J J; McDonagh T A; Robb S D; Clements S; Ford I; McMurray J J; Dargie H J
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.
Heart (British Cardiac Society) 1997;78(6):594-7.
1997: Clark A L; Galloway S; MacFarlane N; Henderson E; Aitchison T; McMurray J J
Catecholamines contribute to exertional dyspnoea and to the ventilatory response to exercise in normal humans.
European heart journal 1997;18(11):1829-33.
1997: McMurray J J; McGuire A; Davie A P; Hughes D
Cost-effectiveness of different ACE inhibitor treatment scenarios post-myocardial infarction.
European heart journal 1997;18(9):1411-5.
1997: McDonagh T A; Morrison C E; Lawrence A; Ford I; Tunstall-Pedoe H; McMurray J J; Dargie H J
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.
Lancet 1997;350(9081):829-33.
1997: McDonagh T A; Woodward M; Morrison C E; McMurray J J; Tunstall-Pedoe H; Lowe G D; McColl K E; Dargie H J
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population.
European heart journal 1997;18(8):1257-60.
1997: Davie A P; Francis C M; Caruana L; Sutherland G R; McMurray J J
The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure.
European heart journal 1997;18(6):981-4.
1997: Davie A P; Francis C M; Caruana L; Sutherland G R; McMurray J J
Assessing diagnosis in heart failure: which features are any use?
QJM : monthly journal of the Association of Physicians 1997;90(5):335-9.
1997: Love M P; McMurray J J
Endothelin in heart failure: a promising therapeutic target?
Heart (British Cardiac Society) 1997;77(2):93-4.
1996: Murdoch D R; Byrne J; McDonagh T; Morton J J; McMurray J J
Measurement of brain natriuretic peptide.
Lancet 1996;348(9041):1589.
1996: McMurray J J; Morrison C E
Cost effectiveness of lowering cholesterol. Study greatly underestimates the cost effectiveness of statin treatment.
BMJ (Clinical research ed.) 1996;313(7065):1142; author reply 1144.
1996: Love M P; Haynes W G; Gray G A; Webb D J; McMurray J J
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.
Circulation 1996;94(9):2131-7.
1996: Davie A P; Love M P; McMurray J J
Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction.
BMJ (Clinical research ed.) 1996;313(7052):300-1.
1996: Davie A P; McMurray J J
Cost-benefit analysis of lipid lowering therapy.
European heart journal 1996;17(7):974-5.
1996: Laycock S K; Kane K A; McMurray J; Parratt J R
Captopril and norepinephrine-induced hypertrophy and haemodynamics in rats.
Journal of cardiovascular pharmacology 1996;27(5):667-72.
1996: Love M P; McMurray J J
Endothelin in chronic heart failure: current position and future prospects.
Cardiovascular research 1996;31(5):665-74.
1996: Davie A P; McMurray J J
Economic aspects of treatment with captopril after MI.
European heart journal 1996;17(5):648-50.
1996: Dargie H J; McMurray J J; McDonagh T A
Heart failure--implications of the true size of the problem.
Journal of internal medicine 1996;239(4):309-15.
1996: Davie A P; Francis C M; Love M P; Caruana L; Starkey I R; Shaw T R; Sutherland G R; McMurray J J
Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.
BMJ (Clinical research ed.) 1996;312(7025):222.
1996: Love M P; McMurray J J
Endothelin in congestive heart failure.
Basic research in cardiology 1996;91 Suppl 1():21-9.
1995: Laycock S K; McMurray J; Kane K A; Parratt J R
Effects of chronic norepinephrine administration on cardiac function in rats.
Journal of cardiovascular pharmacology 1995;26(4):584-9.
1995: Clapperton M; Beswick P H; Abdullah I; Dargie H J; Fisher A C; McMurray J
Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.
British journal of clinical pharmacology 1995;40(1):31-5.
1995: Clapperton M; McMurray J; Fisher A C; Dargie H J
Does luminol chemiluminescence detect free radical scavengers?
British journal of clinical pharmacology 1995;39(6):688-91.
1995: Davie A P; McMurray J J
ACE inhibitors and health-care economics.
Coronary artery disease 1995;6(4):315-9.
1995: Francis C M; Caruana L; Kearney P; Love M; Sutherland G R; Starkey I R; Shaw T R; McMurray J J
Open access echocardiography in management of heart failure in the community.
BMJ (Clinical research ed.) 1995;310(6980):634-6.
1994: Clapperton M; McMurray J; Fisher A C; Dargie H J
The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
British journal of clinical pharmacology 1994;38(1):53-6.
1994: Russell J; Spickett C M; Reglinski J; Smith W E; McMurray J; Abdullah I B
Alteration of the erythrocyte glutathione redox balance by N-acetylcysteine, captopril and exogenous glutathione.
FEBS letters 1994;347(2-3):215-20.
1994: Dargie H J; McMurray J J
Diagnosis and management of heart failure.
BMJ (Clinical research ed.) 1994;308(6924):321-8.
1993: Dowell F J; Hamilton C A; McMurray J; Reid J L
Effects of a xanthine oxidase/hypoxanthine free radical and reactive oxygen species generating system on endothelial function in New Zealand white rabbit aortic rings.
Journal of cardiovascular pharmacology 1993;22(6):792-7.
1993: McMurray J; Chopra M; Abdullah I; Smith W E; Dargie H J
Evidence of oxidative stress in chronic heart failure in humans.
European heart journal 1993;14(11):1493-8.
1993: Laycock S K; McMurray J; Kane K A; Parratt J R
Effects of the xanthine oxidase system on cardiac function in anaesthetised rats.
Free radical biology & medicine 1993;15(3):249-55.
1993: McMurray J; McDonagh T; Morrison C E; Dargie H J
Trends in hospitalization for heart failure in Scotland 1980-1990.
European heart journal 1993;14(9):1158-62.
1992: McMurray J; Chopra M; Abdullah I; Smith W E; Dargie H J
Evidence for oxidative stress in unstable angina.
British heart journal 1992;68(5):454-7.
1992: McLay J S; McMurray J; Bridges A; Struthers A D
Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?
European heart journal 1992;13(11):1521-7.
1992: Ray S G; McMurray J J; Morton J J; Dargie H J
Circulating endothelin is not extracted by the pulmonary circulation in man.
Chest 1992;102(4):1143-4.
1992: Ray S G; McMurray J J; Morton J J; Dargie H J
Circulating endothelin in acute ischaemic syndromes.
British heart journal 1992;67(5):383-6.
1992: McMurray J J; Ray S G; Abdullah I; Dargie H J; Morton J J
Plasma endothelin in chronic heart failure.
Circulation 1992;85(4):1374-9.
1992: Chopra M; Beswick H; Clapperton M; Dargie H J; Smith W E; McMurray J
Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
Journal of cardiovascular pharmacology 1992;19(3):330-40.
1991: McMurray J; Abdullah I; Dargie H J; Shapiro D
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
British heart journal 1991;66(5):356-8.
1991: Lang C C; McMurray J J; Moyses C; Struthers A D
Comparison of the effects of ANF 99-126 and ANF 103-126 on captopril-induced renin release in man.
Clinical endocrinology 1991;34(6):493-9.
1991: McMurray J; Chopra M
Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?
British journal of clinical pharmacology 1991;31(4):373-9.
1991: Northridge D B; McMurray J; Dargie H J
Atrial natriuretic factor in chronic heart failure.
Herz 1991;16(2):92-101.
1990: Northridge D B; Grant S; Ford I; Christie J; McLenachan J; Connelly D; McMurray J; Ray S; Henderson E; Dargie H J
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer.
British heart journal 1990;64(5):313-6.
1990: McMurray J J; Lang C C; MacLean D; McDevitt D G; Struthers A D
Neuroendocrine changes post myocardial infarction: effects of xamoterol.
American heart journal 1990;120(1):56-62.
1990: Chopra M; McMurray J; McLay J; Bridges A; Scott N; Smith W E; Belch J J
Oxidative damage in chronic heart failure: protection by captopril through free radical scavenging?
Advances in experimental medicine and biology 1990;264():251-5.
1989: Northridge D B; McMurray J; Ray S; Jardine A; Dargie H J
Release of atrial natriuretic factor after pericardiocentesis for malignant pericardial effusion.
BMJ (Clinical research ed.) 1989;299(6699):603-4.
1989: Seidelin P H; McMurray J J; Brown R A; Struthers A D
The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man.
British journal of clinical pharmacology 1989;27(6):803-9.
1989: Seidelin P H; McMurray J J; Struthers A D
Mechanisms of the antinatriuretic action of physiological doses of angiotensin II in man.
Clinical science (London, England : 1979) 1989;76(6):653-8.
1989: Lipworth B J; McMurray J J; Clark R A; Struthers A D
Development of persistent late onset asthma following treatment with captopril.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1989;2(6):586-8.
1989: Chopra M; Scott N; McMurray J; McLay J; Bridges A; Smith W E; Belch J J
Captopril: a free radical scavenger.
British journal of clinical pharmacology 1989;27(3):396-9.
1989: McMurray J J; Seidelin P H; Brown R A; Struthers A D
Noradrenaline attenuates the natriuretic effect of atrial natriuretic factor in man.
British journal of clinical pharmacology 1989;27(1):7-12.
1989: McMurray J J; Struthers A D
Atrial natriuretic factor inhibits isoproterenol- and furosemide-stimulated renin release in humans.
Hypertension 1989;13(1):9-14.
1988: McMurray J J; Seidelin P H; Balfour D J; Struthers A D
Physiological increases in circulating noradrenaline are antinatriuretic in man.
Journal of hypertension 1988;6(9):757-61.
1987: McMurray J J; Struthers A D
Renal effects of angiotensin II, atrial natriuretic peptide and their interaction in man.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1987;5(5):S59-62.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

john mcmurray

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of john mcmurray (preview)

All Publications